Table 3.
Univariate COX regression analysis of influencing factors of OSCC patients death
| Variable | β | SE | Wald χ2 | HR (CI 95%) | p |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 1.000 | ||||
| Female | − 0.174 | 0.372 | 0.217 | 0.841 (0.405–1.744) | 0.641 |
| Age | |||||
| < 60 years | 1.000 | ||||
| ≥ 60 years | − 0.035 | 0.372 | 0.009 | 0.966 (0.465–2.004) | 0.925 |
| Differentiation | |||||
| Poor-moderately | 1.000 | ||||
| Well | − 0.809 | 0.354 | 5.214 | 0.445 (0.222–0.892) | 0.022 |
| T stage | |||||
| T1–2 | 1.000 | ||||
| T3–4 | 1.019 | 0.357 | 8.146 | 2.769 (1.376–5.574) | 0.004 |
| N stage | |||||
| N0 | 1.000 | ||||
| N+ | 1.454 | 0.535 | 7.385 | 4.279 (1.5–12.209) | 0.007 |
| Clinical stage | |||||
| I–II | 1.000 | ||||
| III–IV | 1.784 | 0.73 | 5.969 | 5.956 (1.423–24.929) | 0.015 |
| Recurrence | |||||
| No | 1.000 | ||||
| Yes | 1.175 | 0.354 | 11.02 | 3.238 (1.618–6.48) | 0.001 |
P. gingivalis, Porphyromonas gingivalis; CXCL2, C-X-C motif chemokine ligand 2; TANs, Tumour-associated neutrophils
*p < 0.05; **p < 0.01, ***p < 0.001